Michael Z Gilcrease
Overview
Explore the profile of Michael Z Gilcrease including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1551
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo H, Ding Q, Gong Y, Gilcrease M, Zhao M, Zhao J, et al.
Breast Cancer Res
. 2020 Jun;
22(1):69.
PMID: 32576238
Background: In the evaluation of PD-L1 expression to select patients for anti-PD-1/PD-L1 treatment, uniform guidelines that account for different immunohistochemistry assays, different cell types and different cutoff values across tumor...
2.
Candelaria R, Adrada B, Wei W, Thompson A, Santiago L, Lane D, et al.
Eur J Radiol
. 2019 Apr;
114:167-174.
PMID: 31005169
Objective: Different molecular subtypes of triple-negative breast cancer (TNBC) have previously been identified through analysis of gene expression profiles. The luminal androgen receptor (LAR) subtype has been shown to have...
3.
Dave B, Gonzalez D, Liu Z, Li X, Wong H, Granados S, et al.
J Natl Cancer Inst
. 2017 Jan;
109(6).
PMID: 28040796
Background: Metaplastic breast cancer is one of the most therapeutically challenging forms of breast cancer because of its highly heterogeneous and chemoresistant nature. We have previously demonstrated that ribosomal protein...
4.
Ilmer M, Mazurek N, Gilcrease M, Byrd J, Woodward W, Buchholz T, et al.
Breast Cancer Res
. 2016 Oct;
18(1):97.
PMID: 27687248
Background: Galectin-3 (Gal3) plays diverse roles in cancer initiation, progression, and drug resistance depending on tumor type characteristics that are also associated with cancer stem cells (CSCs). Recurrence of breast...
5.
Gilcrease M, Dogan B, Black D, Contreras A, Dryden M, Jimenez S
Am J Surg Pathol
. 2016 Sep;
40(10):1375-9.
PMID: 27627744
Radioactive seed localization is a new procedure for localizing breast lesions that has several advantages over the standard wire-localization procedure. It is reported to be safe for both patients and...
6.
Caudle A, Yang W, Krishnamurthy S, Mittendorf E, Black D, Gilcrease M, et al.
J Clin Oncol
. 2016 Jan;
34(10):1072-8.
PMID: 26811528
Purpose: Placing clips in nodes with biopsy-confirmed metastasis before initiating neoadjuvant therapy allows for evaluation of response in breast cancer. Our goal was to determine if pathologic changes in clipped...
7.
Huo L, Gong Y, Guo M, Gilcrease M, Wu Y, Zhang H, et al.
Histopathology
. 2015 Jan;
67(2):245-54.
PMID: 25564996
Aims: We have demonstrated previously that gross cystic disease fluid protein-15 (GCDFP-15) and mammaglobin A (MAM) are of limited utility in triple-negative breast cancer (TNBC). GATA-binding protein 3 (GATA-3) is...
8.
Nayak A, Carkaci S, Gilcrease M, Liu P, Middleton L, Bassett Jr R, et al.
Clin Breast Cancer
. 2013 Oct;
13(6):439-49.
PMID: 24119786
Background: The management of benign papilloma (BP) without atypia identified on breast core needle biopsy (CNB) is controversial. In this study, we determined the upgrade rate to malignancy for BPs...
9.
10.
Nayak A, Wu Y, Gilcrease M
Am J Surg Pathol
. 2013 May;
37(6):867-73.
PMID: 23629447
Studies evaluating the biological behavior of primary squamous cell carcinoma (SCC) of the breast have yielded inconsistent results, perhaps in part because most studies have not taken into consideration specific...